Science Explorer Back to mapMap

Most cited papers from UK Dementia Research Institute

What are the most cited papers from UK Dementia Research Institute?

The most cited paper from UK Dementia Research Institute is "The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease" (Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al., 2011), with 19,132 citations. Next come "Dementia prevention, intervention, and care" (6,271) and "Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science" (6,092).

Showing 50 of 59 papers. Every paper with more than 911 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Guy M. McKhann, David S. Knopman, Howard Mark Chertkow et al. · Alzheimer s & Dementia Open access 22 Apr 2011 19,132
2 Dementia prevention, intervention, and care Gill Livingston et al. · The Lancet 20 Jul 2017 6,271
3 Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science Emily Alexandra Holmes et al. · The Lancet Psychiatry Open access 15 Apr 2020 6,092
4 Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration Joanna Marguerite Wardlaw et al. · The Lancet Neurology Open access 15 Jul 2013 5,550
5 The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Matthew James Page et al. PreprintOpen access 14 Sep 2020 5,396
6 Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Katya Rascovsky et al. · Brain Open access 2 Aug 2011 5,386
7 Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease European Alzheimer's Disease Initiative (EADI) et al. · Nature Genetics ReviewOpen access184 authors 27 Oct 2013 4,711
8 Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission Gill Livingston et al. · The Lancet Open access 31 Jul 2024 3,635
9 Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Denise H. Harold et al. · Nature Genetics Open access 6 Sep 2009 3,422
10 Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria Bruno Dubois et al. · The Lancet Neurology Open access 18 May 2014 3,373
11 Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing Brian W. Kunkle et al. · Nature Genetics ReviewOpen access469 authors 28 Feb 2019 3,277
12 Mapping genomic loci implicates genes and synaptic biology in schizophrenia Vassily Vladimirovich Trubetskoy et al. · Nature Open access613 authors 8 Apr 2022 2,894
13 Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1 Daniel J. Klionsky et al. · Autophagy Open access2,930 authors 2 Jan 2021 2,743
14 Generalised Dice Overlap as a Deep Learning Loss Function for Highly Unbalanced Segmentations Carole H. Sudre, Wenqi Li, Tom K. Vercauteren et al. · Lecture notes in computer science Conference paperOpen access 2017 2,701
15 Alzheimer's disease Chris Lane, John Hardy, Jonathan M. Schott · European Journal of Neurology Open access 5 Sep 2017 2,612
16 New insights into the genetic etiology of Alzheimer’s disease and related dementias Céline Bellenguez et al. · Nature Genetics Open access1,266 authors Apr 2022 2,608
17 Reactive astrocyte nomenclature, definitions, and future directions Carole Escartin et al. · Nature Neuroscience Open access 15 Feb 2021 2,503
18 Gut microbiome alterations in Alzheimer’s disease Nicholas M. Vogt, Robert L. Kerby, Kimberly A. Dill‐McFarland et al. · Scientific Reports Open access 13 Oct 2017 2,169
19 The clinical use of structural MRI in Alzheimer disease Giovanni Battista Frisoni, Nick C. Fox, Clifford R. Jack et al. · Nature Reviews Neurology ReviewOpen access Feb 2010 2,139
20 Analysis of shared heritability in common disorders of the brain Verneri Anttila et al. · Science Open access577 authors 21 Jun 2018 2,056
21 Microglia states and nomenclature: A field at its crossroads Rosa Chiara Paolicelli et al. · Neuron Open access Nov 2022 2,047
22 Neurofilaments as biomarkers in neurological disorders Michael Khalil, Charlotte Elisabeth Teunissen, Markus Otto et al. · Nature Reviews Neurology ReviewOpen access 31 Aug 2018 2,042
23 Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria Bruno Dubois et al. · Alzheimer s & Dementia Open access Mar 2016 1,953
24 The Amyloid-β Pathway in Alzheimer’s Disease Harald Juergen Hampel, John Hardy, Kaj Blennow et al. · Molecular Psychiatry Open access 29 Aug 2021 1,929
25 Brain charts for the human lifespan Richard A. I. Bethlehem et al. · Nature Open access223 authors 6 Apr 2022 1,896
26 Revising the definition of Alzheimer's disease: a new lexicon Bruno Dubois et al. · The Lancet Neurology Open access 10 Oct 2010 1,873
27 Image processing and Quality Control for the first 10,000 brain imaging datasets from UK Biobank Fidel Alfaro‐Almagro et al. · NeuroImage Open access 24 Oct 2017 1,809
28 Small vessel disease: mechanisms and clinical implications Joanna Marguerite Wardlaw, Colin Smith, Martin Dichgans · The Lancet Neurology Open access 13 May 2019 1,803
29 Hallmarks of neurodegenerative diseases David M. Wilson, Mark Cookson, Ludo Van Den Bosch et al. · Cell Open access Feb 2023 1,784
30 Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders Sebastian Palmqvist et al. · JAMA Open access 28 Jul 2020 1,657
31 Autophagy in major human diseases Daniel J. Klionsky et al. · The EMBO Journal Open access 30 Aug 2021 1,608
32 SARS-CoV-2 is associated with changes in brain structure in UK Biobank Gwenaëlle Douaud, Soojin Lee, Fidel Alfaro‐Almagro et al. · Nature Open access 7 Mar 2022 1,594
33 Microglia Biology: One Century of Evolving Concepts Marco Prinz, Steffen Jung, Josef Priller · Cell Open access Oct 2019 1,554
34 Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits the Million Veteran Program et al. · Nature Genetics Open access281 authors 17 Sep 2018 1,523
35 Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts Thomas K. Karikari et al. · The Lancet Neurology Open access 22 Apr 2020 1,411
36 Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease Valentina Escott‐Price et al. · PLoS ONE Open access188 authors 12 Jun 2014 1,408
37 Neurofilament light chain as a biomarker in neurological disorders Lorenzo Gaetani, Kaj Blennow, Paolo Calabresi et al. · Journal of Neurology Neurosurgery & Psychiatry Open access 9 Apr 2019 1,390
38 Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution Takahiro Masuda, Roman Sankowski, Ori Staszewski et al. · Nature Open access Feb 2019 1,388
39 Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease Samantha Budd Haeberlein et al. · The Journal of Prevention of Alzheimer s Disease Open access 15 Mar 2022 1,377
40 Autophagy in healthy aging and disease Yahyah Aman, Tomas Schmauck‐Medina, Malene Hansen et al. · Nature Aging Open access 12 Aug 2021 1,335
41 Plasma P-tau181 in Alzheimer’s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer’s dementia Shorena Janelidze, Niklas Mattsson, Sebastian Palmqvist et al. · Nature Medicine Mar 2020 1,306
42 Synergy between amyloid-β and tau in Alzheimer’s disease Marc Aurel Busche, Bradley T. Hyman · Nature Neuroscience Open access 10 Aug 2020 1,265
43 Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study Elisa Majounie et al. · The Lancet Neurology Open access 9 Mar 2012 1,249
44 The effects of social deprivation on adolescent development and mental health Amy C. Orben, Livia Tomova, Sarah‐Jayne Blakemore · The Lancet Child & Adolescent Health Open access 12 Jun 2020 1,227
45 Adolescence as a Sensitive Period of Brain Development Delia Fuhrmann, Lisa J. Knoll, Sarah‐Jayne Blakemore · Trends in Cognitive Sciences ReviewOpen access 24 Sep 2015 1,189
46 The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings Ross W. Paterson et al. · Brain Open access 3 Jul 2020 1,173
47 A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease Douglas P. Wightman et al. · Nature Genetics Open access114 authors Sep 2021 1,128
48 Fast free-form deformation using graphics processing units Marc Modat, Gerard R. Ridgway, Zeike A. Taylor et al. · Computer Methods and Programs in Biomedicine Open access 9 Oct 2009 1,122
49 Neuroimaging standards for research into small vessel disease—advances since 2013 Marco Duering et al. · The Lancet Neurology Open access 23 May 2023 1,118
50 Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis Angela Carmen Vincent, Camilla J. Buckley, Jonathan M. Schott et al. · Brain Open access 27 Feb 2004 1,037

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.